Education
About Us
Working with TipRanks
Follow Us
Anavex Life Sciences (AVXL)
:AVXL
AVXL Analyst Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AVXL Stock 12 Month Forecast
Average Price Target
$20.00
▲(397.51% Upside)
| Highest Price Target$20.00 | Average Price Target$20.00 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$20
Buy
397.51%
Upside
Reiterated
11/28/25
JonesTrading
―
Hold
―
Reiterated
11/14/25
Analysts Are Neutral on Top Healthcare Stocks: Anavex Life Sciences (AVXL), IO Biotech (IOBT)We expect Anavex will resubmit the MAA in 1H26. We note that the FDA advised Anavex to request a meeting to discuss the clinical trial results in AD, indicating their interest in the program. There are too many unknowns, and December meeting minutes will clarify the reasons for the negative CHMP opinion. Anavex could be re-analyzing the data based on SIGMAR1 wildtype or APOE4 biomarkers, and we would have to see the data first before making any changes to our rating.
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$20
Buy
397.51%
Upside
Reiterated
11/28/25
JonesTrading
―
Hold
―
Reiterated
11/14/25
Analysts Are Neutral on Top Healthcare Stocks: Anavex Life Sciences (AVXL), IO Biotech (IOBT)We expect Anavex will resubmit the MAA in 1H26. We note that the FDA advised Anavex to request a meeting to discuss the clinical trial results in AD, indicating their interest in the program. There are too many unknowns, and December meeting minutes will clarify the reasons for the negative CHMP opinion. Anavex could be re-analyzing the data based on SIGMAR1 wildtype or APOE4 biomarkers, and we would have to see the data first before making any changes to our rating.
Best Analysts Covering Anavex Life Sciences
1 Month
xxx
Success Rate
9/17 ratings generated profit
Average Return
+2.13%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.94% of your transactions generating a profit, with an average return of +2.13% per trade.
3 Months
xxx
Success Rate
9/17 ratings generated profit
Average Return
+2.92%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +2.92% per trade.
1 Year
Success Rate
7/17 ratings generated profit
Average Return
-5.92%
reiterated a buy rating 16 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of -5.92% per trade.
2 Years
xxx
Success Rate
3/17 ratings generated profit
Average Return
-39.88%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 17.65% of your transactions generating a profit, with an average return of -39.88% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AVXL Analyst Recommendation Trends
Rating
Jun 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
5
5
3
4
5
Buy
0
0
0
0
0
Hold
0
0
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
3
5
7
Each month's total comprises the sum of three months' worth of ratings.
AVXL Financial Forecast
AVXL Stock Forecast FAQ
What is AVXL’s average 12-month price target, according to analysts?
Based on analyst ratings, Anavex Life Sciences’s 12-month average price target is 20.00.
What is AVXL’s upside potential, based on the analysts’ average price target?
Anavex Life Sciences has 397.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AVXL a Buy, Sell or Hold?
Anavex Life Sciences has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Anavex Life Sciences’s price target?
The average price target for Anavex Life Sciences is 20.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 397.51% Increase from the current price of $4.02.
The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 397.51% Increase from the current price of $4.02.
What do analysts say about Anavex Life Sciences?
Anavex Life Sciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of AVXL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.